Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes (2012)

First Author: Wason J
Attributed to:  Hub in Trials Methodology Research (MRC Biostatistics Unit, Cambridge) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/10543406.2010.528104

PubMed Identifier: 22651118

Publication URI: http://europepmc.org/abstract/MED/22651118

Type: Journal Article/Review

Parent Publication: Journal of Biopharmaceutical Statistics

Issue: 4

ISSN: 1054-3406